Heart_BMJ promotes imaging to detect cardiotoxicity, while JAMA Oncology reports CHIP is linked to higher trastuzumab-related cardiotoxicity and heart failure, and JAMA highlights screening disparities tied to breast density.
Cardiac imaging in oncology: the detection of cardiotoxicity
CHIP was associated with higher risk of trastuzumab-related cardiotoxicity and heart failure
Breast density increases cancer risk and reduces #Mammography sensitivity
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare